BIOHARVEST SCIENCES INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.26 CAD | +1.96% |
|
0.00% | +20.93% |
Valuation
| Fiscal Period: December | 2020 | 2021 | 2022 |
|---|---|---|---|
| Capitalization 1 | 78.51 | 165 | 98.54 |
| Enterprise Value (EV) 1 | 79.44 | 163.6 | 107.4 |
| P/E ratio | -9.12 x | -16.1 x | -8.7 x |
| Yield | - | - | - |
| Capitalization / Revenue | 198 x | 78.5 x | 17.9 x |
| EV / Revenue | 201 x | 77.8 x | 19.5 x |
| EV / EBITDA | -14.4 x | -19.4 x | -10.4 x |
| EV / FCF | -22,044,793 x | -42,754,573 x | -15,150,676 x |
| FCF Yield | -0% | -0% | -0% |
| Price to Book | -31.6 x | 57.8 x | -16.6 x |
| Nbr of stocks (in thousands) | 444,455 | 453,630 | 460,716 |
| Reference price 2 | 0.1766 | 0.3638 | 0.2139 |
| Announcement Date | 4/29/21 | 4/28/22 | 4/27/23 |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Net sales 1 | 0.325 | 0.449 | 0.218 | 0.396 | 2.102 | 5.498 |
| EBITDA 1 | -1.654 | -2.515 | -2.247 | -5.519 | -8.426 | -10.33 |
| EBIT 1 | -1.738 | -2.585 | -2.31 | -5.567 | -8.491 | -10.61 |
| Operating Margin | -534.77% | -575.72% | -1,059.63% | -1,405.81% | -403.95% | -193.02% |
| Earnings before Tax (EBT) 1 | -1.846 | -7.472 | -5.31 | -6.584 | -9.827 | -11.24 |
| Net income 1 | -1.846 | -6.673 | -4.27 | -6.584 | -9.827 | -11.24 |
| Net margin | -568% | -1,486.19% | -1,958.72% | -1,662.63% | -467.51% | -204.37% |
| EPS | - | -0.7075 | -0.3400 | -0.0194 | -0.0226 | -0.0246 |
| Free Cash Flow | - | 0.1132 | -2.076 | -3.604 | -3.826 | -7.086 |
| FCF margin | - | 25.22% | -952.24% | -910.04% | -182.02% | -128.88% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 4/21/20 | 4/21/20 | 4/29/20 | 4/29/21 | 4/28/22 | 4/27/23 |
1USD in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 16.5 | 18.1 | 23.1 | 0.93 | - | 8.82 |
| Net Cash position 1 | - | - | - | - | 1.46 | - |
| Leverage (Debt/EBITDA) | -9.954 x | -7.183 x | -10.29 x | -0.1689 x | - | -0.8543 x |
| Free Cash Flow | - | 0.11 | -2.08 | -3.6 | -3.83 | -7.09 |
| ROE (net income / shareholders' equity) | - | 35.3% | 21.4% | 45% | -3,510% | 731% |
| ROA (Net income/ Total Assets) | - | -90.1% | -73.7% | -95% | -68.4% | -67.7% |
| Assets 1 | - | 7.41 | 5.791 | 6.931 | 14.36 | 16.6 |
| Book Value Per Share | - | -2.790 | -3.240 | -0.0100 | 0.0100 | -0.0100 |
| Cash Flow per Share | - | 0.1300 | 0.1000 | 0 | 0.0100 | 0 |
| Capex 1 | 0.04 | 0.05 | 0.03 | 0.17 | 1.64 | 1.26 |
| Capex / Sales | 11.38% | 11.8% | 15.6% | 43.69% | 78.02% | 22.84% |
| Announcement Date | 4/21/20 | 4/21/20 | 4/29/20 | 4/29/21 | 4/28/22 | 4/27/23 |
1USD in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| +20.93% | 109M | |
| +8.20% | 7.78B | |
| +0.34% | 7.38B | |
| +10.20% | 6.52B | |
| -8.10% | 3.67B | |
| -13.13% | 3.44B | |
| -14.57% | 1.17B | |
| +8.34% | 934M | |
| -42.27% | 879M | |
| -18.90% | 836M |
- Stock Market
- Equities
- BHSC Stock
- Financials BioHarvest Sciences Inc.
